Sign in

CIK 0000715446

  • Non-accelerated filer
  • Smaller reporting company

Anixa Biosciences Inc

Sign in to watch
Ticker
ANIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Oct 31
Incorporated
DE
Entity type
Operating
EIN
112622630
Phone
+1 408-708-9808
Business address
3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
Former names
ITUS Corp, COPYTELE INC
  1. 4 Open-market buy Chief Executive Officer bought 4,480 shares at $3.99 ($17,875)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Open-market sale Director sold 25,000 shares at $4.64 ($116,000)
  6. 4/A Grant or award Director acquired 50,000 shares (grant or award)
  7. 4 Exercise or conversion Director acquired 2,400 shares (option exercise)
  8. 4 Grant or award Director acquired 50,000 shares (grant or award)
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award Director acquired 50,000 shares (grant or award)
  11. 4 Grant or award Director acquired 50,000 shares (grant or award)
  12. 4 Grant or award Director acquired 50,000 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4/A Derivatives Options or other derivatives
  15. 3/A Insider 3/A
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 10 of 24 · 471 filings